Literature DB >> 1942057

Structure of the hirugen and hirulog 1 complexes of alpha-thrombin.

E Skrzypczak-Jankun1, V E Carperos, K G Ravichandran, A Tulinsky, M Westbrook, J M Maraganore.   

Abstract

The isomorphous structures of the hirugen (N-acetylhirudin 53'-64' with sulfato-Tyr63') and hirulog 1 (D-Phe-Pro-Arg-Pro-(Gly)4 desulfato-Tyr63'-hirugen) complexes of human alpha-thrombin have been determined and refined at 2.2 A resolution to crystallographic R-factors of 0.167 and 0.163, respectively. The binding of hirugen to thrombin is similar to that of the binding of the C-terminal dodecapeptide of hirudin, including that of the terminal 3(10) helical turn. The sulfato Tyr63', which, as a result of sulfation, increases the binding affinity by an order of magnitude, is involved in an extended hydrogen bonding network utilizing all three sulfato oxygen atoms. The hirugen-thrombin complex is the first thrombin structure determined to have an unobstructed active site; this site is practically identical in positioning of catalytic residues and in its hydrogen bonding pattern with that of other serine proteinases. Hirulog 1, which is a poor thrombin substrate, is cleaved at the Arg3'-Pro4' bond in the crystal structure. The Arg3' of hirulog 1 occupies the specificity site, the D-Phe-Pro-Arg tripeptide is positioned like that of D-Phe-Pro-Arg chloromethylketone in the active site and the Pro4'(Gly)4 spacer to hirugen is disordered in the structure, as is the 3(10) turn of hirugen. The latter must be related to the simultaneous absence both of sulfation and of the last residue of hirudin (Gln65'). In addition, the autolysis loop of thrombin (Lys145-Gly150) is disordered in both structures. Changes in circular dichroism upon hirugen binding are therefore most likely the result of the flexibility associated with this loop.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1942057

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  53 in total

1.  Clotting for the Clinician: An Overview of Thrombosis and Antithrombotic Therapy.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

2.  Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin.

Authors:  A B Kelly; J M Maraganore; P Bourdon; S R Hanson; L A Harker
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

Review 3.  Small bite, large impact-saliva and salivary molecules in the medicinal leech, Hirudo medicinalis.

Authors:  Jan-Peter Hildebrandt; Sarah Lemke
Journal:  Naturwissenschaften       Date:  2011-11-09

Review 4.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

5.  Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12).

Authors:  Christopher T Veldkamp; Christoph Seibert; Francis C Peterson; Thomas P Sakmar; Brian F Volkman
Journal:  J Mol Biol       Date:  2006-05-11       Impact factor: 5.469

6.  Crystal structure of a biosynthetic sulfo-hirudin complexed to thrombin.

Authors:  Chang C Liu; Eric Brustad; Wenshe Liu; Peter G Schultz
Journal:  J Am Chem Soc       Date:  2007-08-09       Impact factor: 15.419

7.  Restoring the procofactor state of factor Va-like variants by complementation with B-domain peptides.

Authors:  Matthew W Bunce; Mettine H A Bos; Sriram Krishnaswamy; Rodney M Camire
Journal:  J Biol Chem       Date:  2013-09-06       Impact factor: 5.157

8.  Rational design of hirulog-type inhibitors of thrombin.

Authors:  U Egner; G A Hoyer; W D Schleuning
Journal:  J Comput Aided Mol Des       Date:  1994-10       Impact factor: 3.686

Review 9.  Novel antithrombotic drugs in development.

Authors:  M Verstraete; P Zoldhelyi
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

10.  The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.

Authors:  J Vijayalakshmi; K P Padmanabhan; K G Mann; A Tulinsky
Journal:  Protein Sci       Date:  1994-12       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.